Rachel Cohen

INDOLE ACETIC ACID AS AN INHIBITOR OF MYELOPEROXIDASE-MEDIATED BYSTANDER TISSUE DAMAGE IN INFLAMMATORY BOWEL DISEASE

Ji Yeon Kim, Rachel Cohen, Liheng Zhou, Noah Thompson et autres

Hospitalisation trends of respiratory syncytial virus (RSV) infection in adults, six European countries, before and during COVID-19, 2016 to 2023

Arantxa Urchueguía-Fornes, Richard Osei‐Yeboah, Ombeline Jollivet, Caroline Klint Johannesen et autres

BACKGROUNDRespiratory syncytial virus (RSV) is a major cause of morbidity in older adults.AIMWe aimed to investigate the epidemiology of RSV in adults in five European countries and one region before and during the COVID-19 era.METHODSWe conducted a retrospective analysis using national hospital …

es, gb, fr, dk, fi, nl, us (code pays fourni par la source)

Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States

Hung Fu Tseng, Lina S. Sy, Bradley K. Ackerson, Emily A. Rayens et autres

BACKGROUND: Recombinant zoster vaccine (RZV) was approved for adults aged ≥50 years in the United States to prevent herpes zoster (HZ) and postherpetic neuralgia (PHN). This study evaluated real-world vaccine effectiveness (VE) of RZV in adults aged ≥50 years. METHODS: A cohort …

us (code pays fourni par la source)

Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre- and post-COVID-19 pandemic

Ombeline Jollivet, Arantxa Urchueguía-Fornes, Kocfa Chung-Delgado, Caroline Klint Johannesen et autres

OBJECTIVES: Respiratory syncytial virus (RSV) is a substantial cause of hospital admission in young children and leads to seasonal pressure on pediatric emergency units in most countries. This study aims to assemble national or large-scale data on RSV hospitalisations from six European …

fr, es, dk, fi, nl, us, ca, gb (code pays fourni par la source)

Next-generation sequencing guides diagnosis and treatment in a complex presentation of ALK-positive anaplastic large-cell lymphoma: a case report

Tejasvini Vaid, Thomas S. Gunning, Rachel Cohen, Alexandra Della Pia et autres

Next-generation sequencing (NGS) technology is being increasingly utilized in the management of cancer patients due to its diagnostic, therapeutic, and prognostic value, and potential to inform use of targeted therapy. We report a case wherein performing NGS testing proved to be a …

in, us, il (code pays fourni par la source)

Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling study

Caroline Klint Johannesen, David Gideonse, Richard Osei‐Yeboah, Toni Lehtonen et autres

Background: Respiratory syncytial virus (RSV) can cause severe disease, notably among infants, older adults, and individuals with comorbidities. Non-systematic testing and differences in coding practices affect direct measures of the hospital disease burden. We aim to tackle this issue and estimate RSV-associated …

dk, nl, gb, fi, fr, us, es (code pays fourni par la source)

P-2345. Recent Incidence Rate of Herpes Zoster Among Immunocompetent Adults Aged 18 and Older in the United States

Rachel Cohen, Yves Brabant, Driss Oraichi, Agnes Mwakingwe-Omar et autres

Abstract Background There is a lack of current herpes zoster (HZ) incidence data among younger age groups of immunocompetent adults in the United States (US), with rigorous exclusion criteria for potential immunocompromising (IC) or chronic conditions. Here we assess not only incidence …

us (code pays fourni par la source)

Engagement of students in care delivery for individuals with intellectual and developmental disabilities through interprofessional education

Jane Jomy, Stuart McKinlay, Ben Caplan, Rachel Cohen et autres

Patients with intellectual and developmental disabilities (IDD) do not receive quality medical care, resulting in health disparities. A key contributing factor to poor care delivery is the lack of standardized IDD curriculum in Canadian medical education. Many physicians and nurses report they …

ca, us (code pays fourni par la source)

RSV healthcare burden in adults before and since the emergence of the COVID-19 pandemic in 6 European countries

Arantxa Urchueguía-Fornes, Richard Osei‐Yeboah, Ombeline Jollivet, Caroline Klint Johannesen et autres

Abstract Introduction Respiratory Syncytial Virus (RSV) is a major cause of morbidity in older adults. With the emergence of the coronavirus disease 2019 (COVID-19) and the subsequent changes in respiratory viral circulation, it is crucial to reassess RSV-associated healthcare burden in adults. …

es, gb, fr, dk, fi, nl, us (code pays fourni par la source)

Burden of Respiratory Syncytial Virus–Associated Acute Respiratory Infections During Pregnancy

Sébastien Kenmoe, Helen Y. Chu, Fatimah S. Dawood, Jennifer Milucky et autres

BACKGROUND: With the licensure of maternal respiratory syncytial virus (RSV) vaccines in Europe and the United States, data are needed to better characterize the burden of RSV-associated acute respiratory infections (ARI) in pregnancy. The current study aimed to determine among pregnant individuals …

gb, us, th, cn, Afrique du Sud (code pays fourni par la source)

Validity of Clinical Severity Scores for Respiratory Syncytial Virus: A Systematic Review

Zakariya Sheikh, Ellie Potter, You Li, Rachel Cohen et autres

BACKGROUND: Respiratory syncytial virus (RSV) is a widespread respiratory pathogen, and RSV-related acute lower respiratory tract infections are the most common cause of respiratory hospitalization in children <2 years of age. Over the last 2 decades, a number of severity scores have …

gb, cn, be, us, nl, Afrique du Sud (code pays fourni par la source)

Respiratory Syncytial Virus European Laboratory Network 2022 Survey: Need for Harmonization and Enhanced Molecular Surveillance

Lance D. Presser, Willem M.R. van den Akker, Adam Meijer, Jeroen Aerssens et autres

Respiratory syncytial virus (RSV) is a common pathogen causing mostly cold-like symptoms, but in very young infants and elderly individuals it can lead to severe disease and even death. There are currently promising developments both in vaccine development and in therapeutics that …

nl (code pays fourni par la source)